Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype‐4 chronic hepatitis C patients

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 88, Iss. 12, 2016-12 ,pp. : 2170-2178

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk

By Wu Xiayu   Cheng Jiaoni   Yang Kaiyun  

International Journal of Molecular Sciences, Vol. 17, Iss. 10, 2016-09 ,pp. : 1597-1597

MDPI

Access to resources Recommend Favorite

A Protease Inhibitor with Induction Therapy with Natural Interferon-β in Patients with HCV Genotype 1b Infection

By Kishida Yutaka   Imaizumi Naohiko   Tanimura Hirohisa   Kashiwamura Shinichiro   Kashiwagi Toru  

International Journal of Molecular Sciences, Vol. 17, Iss. 3, 2016-03 ,pp. : 350-350

MDPI

Access to resources Recommend Favorite

Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon‐α treatment in HBeAg‐positive chronic hepatitis B patients

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 90, Iss. 4, 2018-04 ,pp. : 721-729

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized trial of peginterferon alpha‐2b plus low and escalating dose of ribavirin in patients with chronic hepatitis C with high viral load genotype 1

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 4, 2015-04 ,pp. : 625-633

John Wiley & Sons Inc

Access to resources Recommend Favorite